← Evidence map

ArticleOncotarget2015

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin.

Sixian Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25544759